89533-23-3 Usage
Uses
Used in Pharmaceutical Research:
N-(6-amino-pyrimidin-4-yl)-acetamide is used as a starting material or intermediate for the synthesis of various pharmaceuticals and bioactive compounds. Its unique structure and functional groups enable the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, N-(6-amino-pyrimidin-4-yl)-acetamide is used as a building block for the design and synthesis of novel compounds with potential biological activities. Its structural features allow for the exploration of new chemical space and the discovery of innovative therapeutic agents.
Used in Drug Discovery:
N-(6-amino-pyrimidin-4-yl)-acetamide is employed in drug discovery efforts to identify and optimize compounds with potential therapeutic benefits. Its unique chemical properties and potential biological activities make it a valuable tool in the search for new drugs to treat various diseases and conditions.
Used in Organic Synthesis:
In organic synthesis, N-(6-amino-pyrimidin-4-yl)-acetamide serves as a versatile intermediate for the preparation of a wide range of chemical compounds. Its reactivity and functional groups facilitate the synthesis of complex molecules and the development of new synthetic routes.
Check Digit Verification of cas no
The CAS Registry Mumber 89533-23-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,5,3 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 89533-23:
(7*8)+(6*9)+(5*5)+(4*3)+(3*3)+(2*2)+(1*3)=163
163 % 10 = 3
So 89533-23-3 is a valid CAS Registry Number.
89533-23-3Relevant academic research and scientific papers
AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
-
Page/Page column 96, (2012/04/04)
Provided are compounds of Formula I, stereoisomers, tautomers, solvates, prodrugs and pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, methods of using the compound or composition in therapy, and methods of 5 manufacturing a compound of Formula I
